Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
Globe Newswire•06/08/2026•16:05 ET
0
Whiz Insights
Initiated Phase 3 OCEAN-1 trial for patients with idiopathic pulmonary fibrosis-related chronic cough in the second quarter; Phase 3 OCEAN-2 trial expected to initiate in the third quarter of 2026
Initiated Phase 2b LAKE trial for patients with refractory chronic cough in the second quarter; sample size re-estimation expected in the fourth quarter of 2026
Get started
Create a free account to read the full story.